Rapid Testing for Sexually Transmitted Infections in Pregnancy
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to evaluate infection detection and treatment initiation rates for syphilis and HIV before and after integration of the Chembio DPP® HIV-Syphilis rapid POC test into an ongoing Emergency Department (ED) testing program and to determine whether dual rapid testing improves early initiation of HIV therapy in pregnant patients with newly identified HIV infection.
Who Is on the Research Team?
Irene Stafford, M.D., M.S., M.P.H.
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Testing
Implementation of the Chembio DPP® HIV-Syphilis rapid POC test and standard lab-based testing
Treatment Initiation
Early initiation of HIV therapy for pregnant patients with newly identified HIV infection
Follow-up
Participants are monitored for safety and effectiveness after treatment initiation
What Are the Treatments Tested in This Trial?
Interventions
- Chembio HIV/Syphilis rapid Point of Care (POC) test
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.